NASDAQ: ONCY Oncolytics Biotech (NASDAQ: ONCY) Sustains Gains Days After Positive News on Pelareorep, a Treatment For Solid Tumors Oncolytics Biotech Inc (NASDAQ: ONCY) was a big gainer in Tuesday’s trading session, and closed the day with gains of 34.33%. This came a few days after the company announced acceptance of an abstract for a potential new biomarker data from the